14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today ORPN ranks #17377 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Bio Blast Pharma Ltd. Stock Forecast NASDAQ:ORPN

$6.50 (-2.26%)

Volume: 125k

Closed: Dec 03, 2021

Hollow Logo Score: -7.744

Bio Blast Pharma Ltd. Stock Forecast

$6.50 (-2.26%)

Volume: 125k

Closed: Dec 03, 2021

Score Hollow Logo -7.744
Which way will ORPN go? Request

ORPN Stock Risk

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.73 between high and low, or 11.77%. For the last week, the stock has had a daily average volatility of 8.00%.

Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 80 ] The Bio Blast Pharma Ltd. stock currently holds an RSI14 at 24 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.

High volatility in Bio Blast Pharma Ltd. stock price on Friday which ended trading at $6.50
(Updated on Dec 03, 2021)


Sell candidate since 2021-11-18 Loss -21.02%

The Bio Blast Pharma Ltd. stock price fell by -2.26% on the last day (Friday, 3rd Dec 2021) from $6.65 to $6.50. and has now fallen 6 days in a row. During the day the stock fluctuated 11.77% from a day low at $6.20 to a day high of $6.93. The price has fallen in 9 of the last 10 days and is down by -21.02% for this period. Volume has increased on the last day by 44 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 125 thousand shares were bought and sold for approximately $811.54 thousand.

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $6.32 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -37.12% during the next 3 months and, with a 90% probability hold a price between $3.97 and $4.81 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Signals & Forecast

There are few to no technical positive signals at the moment. The Bio Blast Pharma Ltd. stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $6.97 and $8.20. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, November 03, 2021, and so far it has fallen -29.12%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Bio Blast Pharma Ltd. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.73 between high and low, or 11.77%. For the last week, the stock has had a daily average volatility of 8.00%.

Bio Blast Pharma Ltd. is oversold on RSI14 (24). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Bio Blast Pharma Ltd. stock A Buy?

Bio Blast Pharma Ltd. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -7.744

Predicted Opening Price for Bio Blast Pharma Ltd. of Monday, December 6, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 6, 2021 Current price
$6.54 $6.50 (Undervalued)
Strong Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Volatility and Risk
Daily Average Volatility: 8.00 %
Overall Risk: Very High High Medium Low Very Low
Volatility
8.00 %
Daily Average Volatility
Overall Risk

Very High
High
Medium
Low
Very Low

Support & Resistance

Resistance: $7.26
Price: $6.50
No Support Found

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 7.27 11.90 %
6.99 7.61 %
6.82 4.96 %
Current price: 6.50
Support 6.26 -3.62 %
6.09 -6.27 %
5.81 -10.56 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 7.57 16.46 %
7.39 13.69 %
7.26 11.69 %
Current price 6.50
Support 0 .
0 .
0 .

Click to get the best stock tips daily for free!

About Bio Blast Pharma Ltd.

Bio Blast Pharma Ltd., a clinical development-stage biopharmaceutical company, focuses on the identification, licensing, acquisition, development, and commercialization clinically meaningful therapies for patients with rare and ultra-rare genetic diseases. The company’s drug candidates under clinical or preclinical development includes Trehalose 90mg/mL IV solution, a mutant protein stabilizer and autophagy enhancer used for protein-based drugs ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT